A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2
Conditions: Pulmonary Hypertension (World Health Organization Group 2); Heart Failure Interventions: Drug: AZD3427; Drug: Placebo Sponsors: AstraZeneca; Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Cardiology | Heart | Heart Failure | Hypertension | International Medicine & Public Health | Pulmonary Hypertension | Research | Study | WHO